RenovoRx 10-Q: Q3 Revenue $1.07M, Cash $10.4M, Runway Into 2H 2027
RNXT sits 69% above its 52-week low of $0.701.
Summary
RenovoRx's Q3 10-Q shows $1.07 million of revenue, $10.4 million of cash and a stated runway into the second half of 2027, with the $3.6 million quarterly net loss inflated by a $487,000 non-cash warrant remeasurement.
Key Events · Earnings and Guidance · RNXT
-
Q3 Revenue Jumps to $1.07 Million
Revenue was $1.07 million versus $266,000 a year earlier, and $2.5 million for the first nine months versus $885,000. Full-year 2026 guidance held at $3.75 million to $4.25 million.
-
Cash of $10.4 Million, Runway Into 2H 2027
Cash and equivalents rose to $10.4 million at September 30, 2026 from $7.0 million at December 31, 2025, helped by $3.5 million of warrant exercise proceeds; management states funding through at least the next 12 months, into the second half of 2027.
-
Warrant Mark, Not Cash, Widened the Loss
The $3.6 million quarterly net loss includes a $487,000 non-cash change in fair value of the common stock warrant liability tied to the higher share price — no cash outflow and no new shares issued for it.
-
SG&A Nearly Doubled on Sales Build-Out
Selling, general and administrative expense was $2.9 million in Q3 2026 versus $1.7 million a year earlier, while research and development fell to $1.2 million from $1.7 million.
Analysis · RNXT · Industrial Applications And Services
The headline revenue number was already out this evening, but the 10-Q is where the balance sheet shows up: $10.4 million of cash at September 30 against a $10.1 million nine-month operating loss, which management says funds operations into the second half of 2027. That runway claim is what matters for a company still burning roughly $1 million a month — it buys time for the TIGeR-PaC top-line data expected in the second half of 2027 without an immediate raise. The offset: the loss widened year over year as the sales build-out drove SG&A to $2.9 million in the quarter from $1.7 million, and the $3.6 million quarterly net loss includes a $487,000 non-cash warrant remeasurement charge driven by the higher share price — no cash moved and no new shares were issued for that item. Separately, the company withdrew its never-effective November 2025 shelf on October 16, 2026, so it currently has no registered shelf in place.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RNXT was trading at $1.19 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $53.7M. The 52-week trading range was $0.70 to $2.59. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.